Clinical Trial

Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial

Study acronym: HALO-Shock
Recruiting
View on ClinicalTrials.gov →
Summary
Pilot Prospective Randomized Unblinded Pragmatic Trial of Pulmonary Artery Hemodynamic Monitoring Following Hospitalization for Cardiogenic Shock
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2020-06-03; most recent amendment 2026-03-12.
Status change: Active, Not Recruiting → Recruiting 2024-02-09
Status change: Recruiting → Active, Not Recruiting 2023-01-27
Status change: Not Yet Recruiting → Recruiting 2021-02-08
Trial Details
NCT Number NCT04419480
Lead Sponsor Inova Health Care Services
Collaborators: Abbott
Conditions Cardiogenic Shock, Heart Failure, Ambulatory Hemodynamic Monitoring
Enrollment 40 participants
Start Date 2020-12-31
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-16